Healthcare -
Biotechnology - NASDAQ - US
$ 2.66
-0.375 %
$ 7.21 M
Market Cap
-1.28
P/E
CYCN - CAPITAL EXPENDITURES
Capital Expenditures CYCN - Cyclerion Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR